5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell–dependent antitumor immunity J Vincent, G Mignot, F Chalmin, S Ladoire, M Bruchard, A Chevriaux, ... Cancer research 70 (8), 3052-3061, 2010 | 1314 | 2010 |
Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells F Chalmin, S Ladoire, G Mignot, J Vincent, M Bruchard, JP Remy-Martin, ... The Journal of clinical investigation 120 (2), 457-471, 2010 | 1129 | 2010 |
Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth M Bruchard, G Mignot, V Derangère, F Chalmin, A Chevriaux, F Végran, ... Nature medicine 19 (1), 57-64, 2013 | 780 | 2013 |
Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells D Delmas, C Rébé, S Lacour, R Filomenko, A Athias, P Gambert, ... Journal of Biological Chemistry 278 (42), 41482-41490, 2003 | 397 | 2003 |
Specific involvement of caspases in the differentiation of monocytes into macrophages O Sordet, C Rébé, S Plenchette, Y Zermati, O Hermine, W Vainchenker, ... Blood, The Journal of the American Society of Hematology 100 (13), 4446-4453, 2002 | 392 | 2002 |
The receptor NLRP3 is a transcriptional regulator of TH2 differentiation M Bruchard, C Rebé, V Derangère, D Togbé, B Ryffel, R Boidot, ... Nature immunology 16 (8), 859-870, 2015 | 381 | 2015 |
Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotidase expression F Chalmin, G Mignot, M Bruchard, A Chevriaux, F Végran, A Hichami, ... Immunity 36 (3), 362-373, 2012 | 373 | 2012 |
In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival S Ladoire, G Mignot, S Dabakuyo, L Arnould, L Apetoh, C Rébé, ... The Journal of pathology 224 (3), 389-400, 2011 | 270 | 2011 |
Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells D Delmas, C Rebe, O Micheau, A Athias, P Gambert, S Grazide, ... Oncogene 23 (55), 8979-8986, 2004 | 256 | 2004 |
STAT3 activation: A key factor in tumor immunoescape C Rébé, F Végran, H Berger, F Ghiringhelli Jak-stat 2 (1), e23010, 2013 | 252 | 2013 |
Accumulation of MDSC and Th17 cells in patients with metastatic colorectal cancer predicts the efficacy of a FOLFOX–bevacizumab drug treatment regimen E Limagne, R Euvrard, M Thibaudin, C Rébé, V Derangère, A Chevriaux, ... Cancer research 76 (18), 5241-5252, 2016 | 246 | 2016 |
The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells F Végran, H Berger, R Boidot, G Mignot, M Bruchard, M Dosset, ... Nature immunology 15 (8), 758-766, 2014 | 228 | 2014 |
Interleukin-1β and cancer C Rébé, F Ghiringhelli Cancers 12 (7), 1791, 2020 | 201 | 2020 |
Restoring anticancer immune response by targeting tumor-derived exosomes with a HSP70 peptide aptamer J Gobbo, G Marcion, M Cordonnier, AMM Dias, N Pernet, A Hammann, ... Journal of the National Cancer Institute 108 (3), djv330, 2016 | 201 | 2016 |
Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapy S Ladoire, L Arnould, G Mignot, B Coudert, C Rébé, F Chalmin, J Vincent, ... Breast cancer research and treatment 125, 65-72, 2011 | 176 | 2011 |
Caspase-8 prevents sustained activation of NF-κB in monocytes undergoing macrophagic differentiation C Rébé, S Cathelin, S Launay, R Filomenko, L Prévotat, C L'Ollivier, ... Blood 109 (4), 1442-1450, 2007 | 154 | 2007 |
Liver X receptor β activation induces pyroptosis of human and murine colon cancer cells V Derangere, A Chevriaux, F Courtaut, M Bruchard, H Berger, F Chalmin, ... Cell Death & Differentiation 21 (12), 1914-1924, 2014 | 153 | 2014 |
Production of adenosine by ectonucleotidases: a key factor in tumor immunoescape F Ghiringhelli, M Bruchard, F Chalmin, C Rébé BioMed Research International 2012 (1), 473712, 2012 | 152 | 2012 |
Cathepsin B is required for NLRP3 inflammasome activation in macrophages, through NLRP3 interaction A Chevriaux, T Pilot, V Derangère, H Simonin, P Martine, F Chalmin, ... Frontiers in cell and developmental biology 8, 167, 2020 | 134 | 2020 |
Sirtuin-1 activation controls tumor growth by impeding Th17 differentiation via STAT3 deacetylation E Limagne, M Thibaudin, R Euvrard, H Berger, P Chalons, F Végan, ... Cell reports 19 (4), 746-759, 2017 | 119 | 2017 |